Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,023+, returning 14,907.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 14,907.49% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 4,444.6% |
DeFi Development (DFDV) | 2,166.31% |
Zepp Health (ZEPP) | 2,107.31% |
WW International, Inc Common Stock (WW) | 1,893.51% |
Abits (ABTS) | 1,467.4% |
FiEE (FIEE) | 1,166.06% |
Oncology Institute (TOI) | 1,148.37% |
Abivax SA American Depositary Shares (ABVX) | 1,101.8% |
Lizhi (SOGP) | 830.27% |
Global Interactive Technologies (GITS) | 758.92% |
Nova Lifestyle I (NVFY) | 726.02% |
TMC the metals (TMC) | 714.04% |
Airnet Technology (ANTE) | 627.88% |
Dominari (DOMH) | 619.72% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 575.22% |
Nanobiotix (NBTX) | 574.28% |
mF International Limited Ordinary Shares (MFI) | 567.46% |
Better Home & Finance (BETR) | 559.75% |
Above Food Ingredients Inc Common Stock (ABVE) | 534.55% |
Oklo (OKLO) | 531.75% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 531.55% |
ThredUp (TDUP) | 518.75% |
Newegg Commerce (NEGG) | 517.13% |
